Relifast
Brand Name: Relifast
Generic Name: Parecoxib (as sodium)
Active
Registration Number
DRP-13338-03
Dosage Form
Lyophilized Powder for Injection (IM/IV)
Issuance Date
December 23, 2024
Expiry Date
January 30, 2028
Product Information
Philippine FDA product specifications and classification details
Product Specifications
Dosage Strength40 mg
Packaging5 mL Type I Clear Glass Vial Sealed with Bromobutyl Rubber Stopper and Aluminum Flip-Off Seal Cap x 1's / (Box of 10’s)
Classification
C
Classification
Prescription Drug (Rx)
P
Pharmacologic
Selective Cox-2 Inhibitor (Coxib)
A
Application
CLIDP Conversion
Philippine FDA Classification
Active Ingredients (1)
Complete list of active ingredients in this pharmaceutical product.
Parecoxib (as sodium)Active
Monograph: parecoxib (as sodium)